| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 4,021 | 4,930 | 7,463 | 5,872 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 4,021 | 4,930 | 7,463 | 5,872 | | | Operating Expenses | | Research Development | 13,324 | 8,950 | 8,689 | 8,534 | | Selling General and Administrative | 3,808 | 3,629 | 3,687 | 3,817 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (13,111) | (7,649) | (4,913) | (6,479) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,729) | (6,202) | 4,657 | 661 | | Earnings Before Interest And Taxes | (19,840) | (13,851) | (256) | (5,818) | | Interest Expense | 52 | 94 | 76 | 33 | | Income Before Tax | (19,892) | (13,945) | (332) | (5,851) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (19,892) | (13,945) | (332) | (5,851) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (19,892) | (13,945) | (332) | (5,851) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($19,892) | ($13,945) | ($332) | ($5,851) |
|
0.20% Nasdaq 
Income Statement
